Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00109-006-0068-y.

Title:
IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice | Journal of Molecular Medicine
Description:
Iron aggravates the cardiotoxicity of doxorubicin (DOX), a widely used anticancer anthracycline. The amount of iron in the cell is regulated by the iron regulatory proteins (IRPs)-1 and -2 that control the posttranscriptional expression of key iron metabolism genes. In vitro and cell culture studies revealed the ability of DOX to modulate the activity of both IRPs. However, conflicting data were obtained from different cell types and experimental conditions. To investigate the connection between acute DOX cardiotoxicity and the IRPs in a mammalian organism, we analyzed IRP activity and the expression of IRP target genes in the heart of mice subjected to DOX treatment. DOX exposure elicits a differential modulation of the two IRPs with reduced IRP2 activity and unchanged IRP1 activity. IRP2 downmodulation is associated with the upregulation of the ferritin L and H genes and decreased expression of the transferrin receptor 1 (TfR1). To directly test the role of IRP1 in DOX cardiotoxicity, the DOX response was analyzed in mice lacking IRP1. DOX-mediated IRP2 downmodulation and regulation of ferritin and TfR1 expression is identical in Irp1 βˆ’/βˆ’ mice compared to wild type, as is the degree of oxidative damage of the heart assessed by thioredoxin and thiobarbituric acid reactive substance levels and by brain natriuretic peptide mRNA expression. These data demonstrate that the alterations of cardiac iron homeostasis related to acute anthracycline cardiotoxicity occur independently of IRP1. The observed IRP2 downmodulation could serve as a means to counteract DOX cardiotoxicity by reducing the β€œfree” cellular iron pool.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't figure out the monetization strategy.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {πŸ”}

article, pubmed, google, scholar, cas, iron, irp, cardiotoxicity, regulatory, mice, cairo, expression, ferritin, protein, doxorubicin, dox, activity, molecular, metabolism, galy, hentze, cell, heart, cardiac, genes, role, regulation, privacy, cookies, content, data, journal, anthracycline, proteins, minotti, anthracyclines, cells, blood, biol, chem, analysis, publish, search, alterations, corna, irps, related, access, doxorubicininduced, med,

Topics {βœ’οΈ}

iron-regulatory protein-rna-binding activity month download article/chapter left-ventricular systolic dysfunction oxidant-induced iron signaling end-stage heart failure p38-mapk/nf-ΞΊb unexpected anthracycline-mediated alterations iron regulatory proteins distinct metabolic pathways doxorubicin-resistant cancer cells full article pdf iron-regulatory protein 2 dox-mediated irp2 downmodulation doxorubicin-induced cardiotoxicity iron-mediated toxicity european economic area iron-dependent stability doxorubicin-induced cardiomyopathy iron metabolism induced cardiac iron metabolism article corna privacy choices/manage cookies related subjects molecular medicine aims thiobarbituric acid reaction doxorubicin-treated mice irp1-independent alterations οΏ½free” iron pool heavy subunit sequences iron-mediated cardiotoxicity nf-kappab activation reactive oxygen species tumor necrosis factor rt-pcr analysis reduced irp2 activity gaetano cairo observed irp2 downmodulation acute dox cardiotoxicity ferritin gene expression superoxide dismutase activity heart cell mitochondria transformed endothelial cells doxorubicin-mediated apoptosis rat heart cells unchanged irp1 activity secondary alcohol metabolite increased mitochondrial efficiency maria paola santini article journal doxorubicin-induced

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice
         description:Iron aggravates the cardiotoxicity of doxorubicin (DOX), a widely used anticancer anthracycline. The amount of iron in the cell is regulated by the iron regulatory proteins (IRPs)-1 and -2 that control the posttranscriptional expression of key iron metabolism genes. In vitro and cell culture studies revealed the ability of DOX to modulate the activity of both IRPs. However, conflicting data were obtained from different cell types and experimental conditions. To investigate the connection between acute DOX cardiotoxicity and the IRPs in a mammalian organism, we analyzed IRP activity and the expression of IRP target genes in the heart of mice subjected to DOX treatment. DOX exposure elicits a differential modulation of the two IRPs with reduced IRP2 activity and unchanged IRP1 activity. IRP2 downmodulation is associated with the upregulation of the ferritin L and H genes and decreased expression of the transferrin receptor 1 (TfR1). To directly test the role of IRP1 in DOX cardiotoxicity, the DOX response was analyzed in mice lacking IRP1. DOX-mediated IRP2 downmodulation and regulation of ferritin and TfR1 expression is identical in Irp1 βˆ’/βˆ’ mice compared to wild type, as is the degree of oxidative damage of the heart assessed by thioredoxin and thiobarbituric acid reactive substance levels and by brain natriuretic peptide mRNA expression. These data demonstrate that the alterations of cardiac iron homeostasis related to acute anthracycline cardiotoxicity occur independently of IRP1. The observed IRP2 downmodulation could serve as a means to counteract DOX cardiotoxicity by reducing the β€œfree” cellular iron pool.
         datePublished:2006-06-13T00:00:00Z
         dateModified:2006-06-13T00:00:00Z
         pageStart:551
         pageEnd:560
         sameAs:https://doi.org/10.1007/s00109-006-0068-y
         keywords:
            Iron
            Anthracyclines
            Heart
            Cardiotoxicity
            Iron regulatory proteins
            Molecular Medicine
            Human Genetics
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig5_HTML.gif
         isPartOf:
            name:Journal of Molecular Medicine
            issn:
               1432-1440
               0946-2716
            volumeNumber:84
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gianfranca Corna
               affiliation:
                     name:University of Milan
                     address:
                        name:Institute of General Pathology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bruno Galy
               affiliation:
                     name:European Molecular Biology Laboratory
                     address:
                        name:European Molecular Biology Laboratory, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Matthias W. Hentze
               affiliation:
                     name:European Molecular Biology Laboratory
                     address:
                        name:European Molecular Biology Laboratory, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gaetano Cairo
               affiliation:
                     name:University of Milan
                     address:
                        name:Institute of General Pathology, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice
      description:Iron aggravates the cardiotoxicity of doxorubicin (DOX), a widely used anticancer anthracycline. The amount of iron in the cell is regulated by the iron regulatory proteins (IRPs)-1 and -2 that control the posttranscriptional expression of key iron metabolism genes. In vitro and cell culture studies revealed the ability of DOX to modulate the activity of both IRPs. However, conflicting data were obtained from different cell types and experimental conditions. To investigate the connection between acute DOX cardiotoxicity and the IRPs in a mammalian organism, we analyzed IRP activity and the expression of IRP target genes in the heart of mice subjected to DOX treatment. DOX exposure elicits a differential modulation of the two IRPs with reduced IRP2 activity and unchanged IRP1 activity. IRP2 downmodulation is associated with the upregulation of the ferritin L and H genes and decreased expression of the transferrin receptor 1 (TfR1). To directly test the role of IRP1 in DOX cardiotoxicity, the DOX response was analyzed in mice lacking IRP1. DOX-mediated IRP2 downmodulation and regulation of ferritin and TfR1 expression is identical in Irp1 βˆ’/βˆ’ mice compared to wild type, as is the degree of oxidative damage of the heart assessed by thioredoxin and thiobarbituric acid reactive substance levels and by brain natriuretic peptide mRNA expression. These data demonstrate that the alterations of cardiac iron homeostasis related to acute anthracycline cardiotoxicity occur independently of IRP1. The observed IRP2 downmodulation could serve as a means to counteract DOX cardiotoxicity by reducing the β€œfree” cellular iron pool.
      datePublished:2006-06-13T00:00:00Z
      dateModified:2006-06-13T00:00:00Z
      pageStart:551
      pageEnd:560
      sameAs:https://doi.org/10.1007/s00109-006-0068-y
      keywords:
         Iron
         Anthracyclines
         Heart
         Cardiotoxicity
         Iron regulatory proteins
         Molecular Medicine
         Human Genetics
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-006-0068-y/MediaObjects/109_2006_68_Fig5_HTML.gif
      isPartOf:
         name:Journal of Molecular Medicine
         issn:
            1432-1440
            0946-2716
         volumeNumber:84
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gianfranca Corna
            affiliation:
                  name:University of Milan
                  address:
                     name:Institute of General Pathology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bruno Galy
            affiliation:
                  name:European Molecular Biology Laboratory
                  address:
                     name:European Molecular Biology Laboratory, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Matthias W. Hentze
            affiliation:
                  name:European Molecular Biology Laboratory
                  address:
                     name:European Molecular Biology Laboratory, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gaetano Cairo
            affiliation:
                  name:University of Milan
                  address:
                     name:Institute of General Pathology, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Molecular Medicine
      issn:
         1432-1440
         0946-2716
      volumeNumber:84
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Milan
      address:
         name:Institute of General Pathology, University of Milan, Milan, Italy
         type:PostalAddress
      name:European Molecular Biology Laboratory
      address:
         name:European Molecular Biology Laboratory, Heidelberg, Germany
         type:PostalAddress
      name:European Molecular Biology Laboratory
      address:
         name:European Molecular Biology Laboratory, Heidelberg, Germany
         type:PostalAddress
      name:University of Milan
      address:
         name:Institute of General Pathology, University of Milan, Milan, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gianfranca Corna
      affiliation:
            name:University of Milan
            address:
               name:Institute of General Pathology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Bruno Galy
      affiliation:
            name:European Molecular Biology Laboratory
            address:
               name:European Molecular Biology Laboratory, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Matthias W. Hentze
      affiliation:
            name:European Molecular Biology Laboratory
            address:
               name:European Molecular Biology Laboratory, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Gaetano Cairo
      affiliation:
            name:University of Milan
            address:
               name:Institute of General Pathology, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of General Pathology, University of Milan, Milan, Italy
      name:European Molecular Biology Laboratory, Heidelberg, Germany
      name:European Molecular Biology Laboratory, Heidelberg, Germany
      name:Institute of General Pathology, University of Milan, Milan, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(151)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.2s.